Ozempic & GLP-1
Connecting the harm with diabetes-suffering class against gastrointestinal complications after using Ozempic, Wegovy, and other GLP-1 agonists.
Case Overview
Common, Wegovy, and other GLP-1 receptor agonists have exploded in popularity for diabetes management and weight loss. However, these drugs have been linked to severe gastrointestinal issues, most notably gastroparesis (stomach paralysis), which can cause lifelong complications.
Lawsuits allege that manufacturers failed to adequately warn patients and doctors about the risk of severe stomach paralysis and other gastrointestinal injuries associated with these medications.
With millions of prescriptions written annually, the potential claimant pool for this litigation is substantial and growing rapidly.
We expect far-specific criteria to ensure lead quality for Ozempic and GLP-1 litigation.
The primary injuries being pursued in this litigation involve severe gastroparesis/paralysis and obstruction.
Also known as stomach paralysis. A condition where the stomach cannot empty itself of food in a normal fashion, leading to nausea, vomiting, and abdominal pain.
A lack of movement somewhere in the intestines that leads to a buildup and potential blockage of food material.
Cyclic vomiting syndrome or persistent vomiting requiring medical intervention, hospitalization, or feeding dehydration and malnutrition.
Our claimant standards are designed to filter out non-qualifying inquiries and deliver only documented, high-value cases.
We target users actively seeking legal help for specific side effects, not just general drug users.
Our intake process validates the scientific diagnosis of gastroparesis or obstruction to ensure case viability.
We stay updated on MDL criteria to adapt our screening questions as the litigation evolves.
Key Facts
- Drugs Involved: Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity
- Primary Injury: Gastroparesis, Blockages/Paralysis
- Defendants: Novo Nordisk, Eli Lilly
- Litigation Status: Active - Early Stages / MDL Formation
Who Qualifies
Usage Requirements
- Prescribed Ozempic, Wegovy, Mounjaro, or similar GLP-1 agonist
- Used for weight loss or Type 2 Diabetes
- Used for at least 3 months with emergency records
Injury Requirements
- Diagnosed with Gastroparesis (Stomach Paralysis)
- Diagnosed with Ileus (Bowel Obstruction)
- Severe vomiting lasting 4+ weeks
- Required hospitalization or ER visits
Timing
- Symptoms developed while taking the drug or shortly after stopping
- No pre-existing diagnosis of gastroparesis prior to drug use
Exclusions
- Prior gastric bypass surgery
- Certain pre-existing conditions that cause gastroparesis
- Cancer treatment (chemotherapy/radiation)
Linked Complications
Gastroparesis
Also known as stomach paralysis. A condition where the stomach cannot empty itself of food in a normal fashion, leading to nausea, vomiting, and abdominal pain.
Ileus
A lack of movement somewhere in the intestines that leads to a buildup and potential blockage of food material.
Severe Vomiting
Cyclic vomiting syndrome or persistent vomiting requiring medical intervention, hospitalization, or feeding dehydration and malnutrition.
Interested in This Case?
Let's discuss how we can help you acquire qualified leads for this mass tort campaign.